{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "W",
          "alt": "Stop",
          "position": 453
        },
        "variant_string_id": "PARK2 W453Stop"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson’s disease (ARPD). Pathogenic parkin mutations compromise the E3 ligase activity of parkin, leading to the accumulation of parkin substrates, such as CDCrel-1 and Pael-R, which ultimately might damage dopaminergic neurones.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the loss of parkin function, which compromises E3 ligase activity and leads to the accumulation of substrates, causing neuronal damage."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Various pathogenic parkin mutations have been shown to compromise the E3 ligase activity of parkin. The authors used cell culture models to analyze the biogenesis and cellular localization of different disease-associated parkin mutants.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (cell culture models) effectively models the disease pathogenesis by assessing E3 ligase activity and cellular localization."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The authors used wild-type parkin as a control and performed multiple replicates of experiments, as indicated by the use of 'at least three independent experiments'.\n\nStep 3c: Variant Controls: Known pathogenic variants (such as W453Stop) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and null controls were used, and multiple replicates were performed.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The paper does not provide a direct OddsPath calculation but reports significant differences in the stability and activity of parkin mutants compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "Step 4b: No OddsPath Calculation: The paper provides sufficient qualitative evidence without calculating OddsPath."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The W453Stop variant significantly compromises the E3 ligase activity of parkin, leading to rapid misfolding and aggregation. This is supported by multiple replicates and the use of known pathogenic controls."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "E",
          "alt": "Stop",
          "position": 409
        },
        "variant_string_id": "PARK2 E409Stop"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson’s disease (ARPD). Pathogenic parkin mutations compromise the E3 ligase activity of parkin, leading to the accumulation of parkin substrates, such as CDCrel-1 and Pael-R, which ultimately might damage dopaminergic neurones.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the loss of parkin function, which compromises E3 ligase activity and leads to the accumulation of substrates, causing neuronal damage."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Various pathogenic parkin mutations have been shown to compromise the E3 ligase activity of parkin. The authors used cell culture models to analyze the biogenesis and cellular localization of different disease-associated parkin mutants.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (cell culture models) effectively models the disease pathogenesis by assessing E3 ligase activity and cellular localization."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The authors used wild-type parkin as a control and performed multiple replicates of experiments, as indicated by the use of 'at least three independent experiments'.\n\nStep 3c: Variant Controls: Known pathogenic variants (such as E409Stop) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and null controls were used, and multiple replicates were performed.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The paper does not provide a direct OddsPath calculation but reports significant differences in the stability and activity of parkin mutants compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "Step 4b: No OddsPath Calculation: The paper provides sufficient qualitative evidence without calculating OddsPath."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The E409Stop variant significantly compromises the E3 ligase activity of parkin, leading to rapid misfolding and aggregation. This is supported by multiple replicates and the use of known pathogenic controls."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "Q",
          "alt": "Stop",
          "position": 311
        },
        "variant_string_id": "PARK2 Q311Stop"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson’s disease (ARPD). Pathogenic parkin mutations compromise the E3 ligase activity of parkin, leading to the accumulation of parkin substrates, such as CDCrel-1 and Pael-R, which ultimately might damage dopaminergic neurones.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the loss of parkin function, which compromises E3 ligase activity and leads to the accumulation of substrates, causing neuronal damage."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Various pathogenic parkin mutations have been shown to compromise the E3 ligase activity of parkin. The authors used cell culture models to analyze the biogenesis and cellular localization of different disease-associated parkin mutants.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (cell culture models) effectively models the disease pathogenesis by assessing E3 ligase activity and cellular localization."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The authors used wild-type parkin as a control and performed multiple replicates of experiments, as indicated by the use of 'at least three independent experiments'.\n\nStep 3c: Variant Controls: Known pathogenic variants (such as Q311Stop) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and null controls were used, and multiple replicates were performed.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The paper does not provide a direct OddsPath calculation but reports significant differences in the stability and activity of parkin mutants compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "Step 4b: No OddsPath Calculation: The paper provides sufficient qualitative evidence without calculating OddsPath."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Q311Stop variant significantly compromises the E3 ligase activity of parkin, leading to rapid misfolding and aggregation. This is supported by multiple replicates and the use of known pathogenic controls."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": 42
        },
        "variant_string_id": "PARK2 R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of parkin function is the major cause of autosomal recessive Parkinson’s disease (ARPD). Pathogenic parkin mutations compromise the E3 ligase activity of parkin, leading to the accumulation of parkin substrates, such as CDCrel-1 and Pael-R, which ultimately might damage dopaminergic neurones.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the loss of parkin function, which compromises E3 ligase activity and leads to the accumulation of substrates, causing neuronal damage."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Various pathogenic parkin mutations have been shown to compromise the E3 ligase activity of parkin. The authors used cell culture models to analyze the biogenesis and cellular localization of different disease-associated parkin mutants.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (cell culture models) effectively models the disease pathogenesis by assessing E3 ligase activity and cellular localization."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The authors used wild-type parkin as a control and performed multiple replicates of experiments, as indicated by the use of 'at least three independent experiments'.\n\nStep 3c: Variant Controls: Known pathogenic variants (such as R42P) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and null controls were used, and multiple replicates were performed.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The paper does not provide a direct OddsPath calculation but reports significant differences in the stability and activity of parkin mutants compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "Step 4b: No OddsPath Calculation: The paper provides sufficient qualitative evidence without calculating OddsPath."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The R42P variant significantly compromises the E3 ligase activity of parkin, leading to rapid proteasomal degradation. This is supported by multiple replicates and the use of known pathogenic controls."
    }
  ]
}